Summary We have analysed 15 infiltrating duct carcinomas of the breast, 10 gastrointestinal adenocarcinomas, one each of the thyroid and larynx, and four mesenchymal tumours for the presence and the nature of procoagulant activity (PCA). The metastatic tumours had a significantly higher PCA (P = 0.01-0.001) as compared to the non-metastatic tumours in the respective groups, and almost 20-25 times the activity as comnpared to normal tissue (P = 0.001). Although the majority of the tumours had FVII-dependent tissue thromboplastin-like activity, some of the tumour homogenates revealed the presence of an FVII-independent PCA. Unlike the known alternate PCA, which acts via factor X activation, this PCA was factor X independent. It caused clot formation in FX-deficient plasma (six cases) and purified fibrinogen solution (four cases), indicating the presence of a Xa-like enzyme or a thrombin-like activity respectively.
As early as 1938, Sproule recognised the association between malignancy and alterations in haemostasis. Since then, it is well known that malignant disease is associated with a high incidence of vascular thrombosis or disseminated intravascular coagulation (Rickles & Edwards, 1983) . Deposition of fibrin within and around the tumour has been convincingly demonstrated immunohistochemically and ultrastructurally (Rickles & Edwards, 1983 ) but its precise role in the growth and spread of the tumour is largely unknown. O'Meara (1958) first described the procoagulant activity of cancer cells. PCA could be present at the cancer cell surface or secreted by it, and may be of two types: (a) FVII-dependent, tissue thromboplastin activity (Rickles & Edwards, 1983; Markus, 1984; Cajot et al., 1986) ; (b) FVII-independent, direct FX activator (Curatolo et al., 1979; Hilgard & Whur, 1980; Gordon & Cross, 1981 
Results

PCA of breast tumours
The mean PCA of metastatic infiltrating duct carcinoma was 76.1 % (range 15-150% of HBT) and was significantly higher (P = 0.01) as compared to the mean PCA of non-metastatic carcinomas (11.3%; range 0-35% of HBT). In the majority of cases PCA was FVII-dependent and FVIII-independent. Three out of nine metastatic tumours contained FX bypassing activity, and one of these three had thrombin-like activity of 10 u ml-'. None of the non-metastatic carcinomas revealed an FX-bypassing activity. Two samples of normal breast tissue had a PCA of 4 and 2.5% respectively. (See Table I.) PCA of GIT tumours The mean PCA of metastatic adenocarcinoma was 120.5%, the range being 86-170% of HBT, and was significantly higher (P = 0.001) than the non-metastatic adenocarcinomas, which had a mean PCA of 7.7% with a range of 2.3-10.5%. PCA was largely FVII-dependent. FX-bypassing activity was present in one of three non-metastatic adenocarcinomas which was thrombin-like and equivalent to 4.7 u ml-'. These activities were not demonstrable in any of the metastatic tumours. (See Table II.) Tissue samples taken from three GIT inflammatory lesions had a mean PCA of 22% (range 10.5-45%), which was also FVII-dependent. FX-bypassing activity was not detected. The mean PCA of metastatic adenocarcinoma was significantly higher (P = 0.001) than the mean PCA of inflammatory lesions.
PCA of ovarian tumours
The mean PCA of four metastatic ovarian carcinomas (two serous and two mucinous) was 112.5% with a range of 56-170% of HBT. FX-bypassing, Xa-like activity was detected in two of four carcinomas. PCA of three normal ovarian tissues ranged between 3 and 9%, the mean value being 6%, which was significantly lower (P = 0.001) than the mean PCA of metastatic carcinomas. (See Table III.) PCA of mesenchymal tumours Samples taken from two cases of angiofibroma had PCA of 1.7% and 17% respectively, one case of dermatofibrosarcoma had PCA of 8% and TH from a specimen of malignant fibrous histiocytoma showed a PCA of 1.6%. FXbypassing activity was present in one case of angiofibroma Table I Table IV.) Apart from these tumours, one case each of papillary carcinoma thyroid (metastatic) and squamous cell carcinoma of larynx (metastatic) were studied. Papillary carcinoma of thyroid had a PCA of 23% and showed an FX-bypassing thrombin-like activity equivalent to 10uml-'. Carcinoma larynx had a PCA of 110% and possessed Xa-like property (0.022 Xa u ml-').
Discussion
Local deposition of fibrin (Cajot et al., 1986) and generalised activation of blood coagulation (Bick, 1978) are frequently observed in experimental animals and patients with malignant tumours. Fibrin mesh-work helps in tumour cell embolisation and thus formation of distant metastasis. The ability of tumour cells to form fibrin is related to the presence of tumour procoagulant activity (Cajot et al., 1986) . The PCA is largely tissue thromboplastin-like, being FVIIdependent, although alternate mechanisms which involve direct FX activation exist (Hilgard & Whur, 1980; Gordon & Cross, 1981) . Zacharski et al. (1987) have reported the occurrence of thrombin-generated cleavage sites of human fibrinogen within the connective tissue stroma adjacent to viable tumour cells in fresh frozen sections of small cell carcinoma of lung by means of immunohistochemistry, thereby providing indirect evidence of thrombin in tumour cells. In our study of human malignant tumours an attempt was made to correlate metastatic potential with the amount of PCA and also to categorise the functional types of PCA from tumours of varied histogenesis.
Initially, the occurrence of PCA was described in tissue homogenates. In recent studies utilising cell culture systems the presence of intracellular, membrane-bound and extracellularly released PCA was confirmed (Rickles & Edwards, 1983; Cajot et al., 1986 The association between the presence of FX-bypassing activity and metastatic potential of malignant tumours cannot be delineated from the above observations. Xa and thrombin-like enzymes may represent some of the proteins synthesised due to aberrant metabolism of neoplastic cells, and if present may provide the tumour cells with alternate pathways for fibrin formation. In conclusion, it can be stated that the increased amount of thromboplastin-like PCA is distinctly associated with tumour dissemination, and reaffirms the necessity of fibrin for tumour metastasis although the cell of origin of PCA in TH can only be ascertained using cell cultures. In addition we have for the first time demonstrated an FX-independent PCA of tumour cells, Xa and thrombin-like activities, although the biological significance of this remains to be elucidated.
